Clinical Trials Browser

Phase 2/3 × durvalumab × Gastrointestinal × Clear all

NCT06904170 2026-02-03

ALICE

Phase 2/3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06109272 2025-08-15

LIVIGNO-2

Phase 2/3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06214572 2025-04-11

RUGB

Phase 2/3 Recruiting

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms